[HTML][HTML] DNA methylation–based immune response signature improves patient diagnosis in multiple cancers

J Jeschke, M Bizet, C Desmedt… - The Journal of …, 2017 - Am Soc Clin Investig
BACKGROUND. The tumor immune response is increasingly associated with better clinical
outcomes in breast and other cancers. However, the evaluation of tumor-infiltrating …

Monitoring of serum DNA methylation as an early independent marker of response and survival in metastatic breast cancer: TBCRC 005 prospective biomarker study

K Visvanathan, MJS Fackler, Z Zhang… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Epigenetic alterations measured in blood may help guide breast cancer treatment.
The multisite prospective study TBCRC 005 was conducted to examine the ability of a novel …

[HTML][HTML] DNA methylation signatures of breast cancer in peripheral T-cells

S Parashar, D Cheishvili, N Mahmood, A Arakelian… - BMC cancer, 2018 - Springer
Background Immune surveillance acts as a defense mechanism in cancer, and its disruption
is involved in cancer progression. DNA methylation reflects the phenotypic identity of cells …

[HTML][HTML] DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer

Q Zou, X Wang, D Ren, B Hu, G Tang… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Tumor-infiltrating lymphocytes (TILs), especially CD8+ TILs, can be used for
predicting immunotherapy responsiveness and survival outcome. However, the evaluation …

[HTML][HTML] Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction

J Oliver, M Garcia-Aranda, P Chaves, E Alba… - Seminars in cancer …, 2022 - Elsevier
Cancer is the second leading cause of death worldwide being responsible for 9.6 million
deaths in 2018. Epigenetic alterations are key in directing the aberrant expression of tumor …

[HTML][HTML] Tumor infiltrating lymphocytes across breast cancer subtypes: current issues for biomarker assessment

C Valenza, B Taurelli Salimbeni, C Santoro, D Trapani… - Cancers, 2023 - mdpi.com
Simple Summary Tumor-infiltrating lymphocytes (TILs) are immune cells that can be
involved in the anti-tumor response and are presently viewed as a promising, inexpensive …

DNA methylation based biomarkers in non-invasive cancer screening

N Shivapurkar, AF Gazdar - Current molecular medicine, 2010 - ingentaconnect.com
DNA methylation plays a critical role in the regulation of gene expression, differentiation and
in the development of cancer and other diseases. Hypermethylation of CpG islands located …

Analysis of DNA methylation in cancer: location revisited

A Koch, SC Joosten, Z Feng, TC de Ruijter… - Nature reviews Clinical …, 2018 - nature.com
Abstract Changes in DNA methylation in cancer have been heralded as promising targets
for the development of powerful diagnostic, prognostic, and predictive biomarkers. Despite …

[HTML][HTML] DNA methylation cancer biomarkers: translation to the clinic

WJ Locke, D Guanzon, C Ma, YJ Liew… - Frontiers in …, 2019 - frontiersin.org
Carcinogenesis is accompanied by widespread DNA methylation changes within the cell.
These changes are characterized by a globally hypomethylated genome with focal …

DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer

C Leygo, M Williams, HC Jin, MWY Chan… - Disease …, 2017 - Wiley Online Library
In light of the high incidence and mortality rates of cancer, early and accurate diagnosis is an
important priority for assigning optimal treatment for each individual with suspected illness …